XML 56 R42.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Stock-Based Compensation (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract] |
Schedule of stock-based compensation expense |
Schedule of stock-based compensation expense |  |  |  |  |  |  |  |  |
|  | For the years ended December 31, |
(dollars in thousands) |  | 2023 |  |  | 2022 |  |  | 2021 |
Stock option expense |  | $ | 528 |  |  |  | 927 |  |  |  | 1,148 |
Restricted stock grant expense |  |  | 1,415 |  |  |  | 1,099 |  |  |  | 499 |
Total stock-based compensation expense |  | $ | 1,943 |  |  |  | 2,026 |  |  |  | 1,647 |
Schedule of the status of the stock option plan and changes |
Schedule of the status of the stock option plan and changes |  |  |  |  |  |
|  | For the years ended December 31, |
|  | 2023 |  |  | 2022 |  |  | 2021 |  |
|  | Shares |  |  | Weighted average exercise price |  |  | Weighted Average Remaining Contractual Life |  |  | Shares |  |  | Weighted average exercise price |  |  | Weighted Average Remaining Contractual Life |  |  | Shares |  |  | Weighted average exercise price |  |  | Weighted Average Remaining Contractual Life |
Outstanding at beginning of year |  |  | 427,224 |  |  | $ | 34.32 |  |  |  |  |  |  | 464,724 |  |  | $ | 33.97 |  |  |  |  |  |  | 495,195 |  |  | $ | 29.93 |  |  |  |
Granted |  |  | - |  |  |  | - |  |  |  |  |  |  | - |  |  |  | - |  |  |  |  |  |  | 121,000 |  |  |  | 40.45 |  |  |  |
Exercised |  |  | (27,250 | ) |  |  | 20.18 |  |  |  |  |  |  | (32,375 | ) |  |  | 27.94 |  |  |  |  |  |  | (127,871 | ) |  |  | 23.56 |  |  |  |
Forfeited or expired |  |  | (68,625 | ) |  |  | 34.15 |  |  |  |  |  |  | (5,125 | ) |  |  | 43.14 |  |  |  |  |  |  | (23,600 | ) |  |  | 38.88 |  |  |  |
Outstanding at end of year |  |  | 331,349 |  |  | $ | 35.51 |  |  | 4.9 years |  |  |  | 427,224 |  |  | $ | 34.32 |  |  | 5.7 years |  |  |  | 464,724 |  |  | $ | 33.97 |  |  | 6.6 years |
Options exercisable at year-end |  |  | 267,376 |  |  | $ | 34.48 |  |  | 4.5 years |  |  |  | 287,902 |  |  | $ | 32.35 |  |  | 4.8 years |  |  |  | 239,340 |  |  | $ | 29.68 |  |  | 5.0 years |
Weighted average fair value of options granted during the year |  |  |  |  |  | $ | - |  |  |  |  |  |  |  |  |  | $ | - |  |  |  |  |  |  |  |  |  | $ | 16.40 |  |  |  |
Shares available for grant |  |  | 319,058 |  |  |  |  |  |  |  |  |  |  | 370,824 |  |  |  |  |  |  |  |  |  |  | 422,550 |  |  |  |  |  |  |  |
Schedule of assumptions used |
Schedule of assumptions used |  |  |  |  |  |  |  |  |
|  | 2023 |  |  | 2022 |  |  | 2021 |
Dividend yield- |  |  | -n/a |  |  |  | n/a |  |  |  | - |
Expected life |  |  | n/a |  |  |  | n/a |  |  |  | 7 years |
Expected volatility |  |  | n/a |  |  |  | n/a |  |  |  | 38.48 | %
Risk-free interest rate |  |  | n/a |  |  |  | n/a |  |  |  | 0.74 | %
Schedule of the status of the company's nonvested restricted stock and changes |
Schedule of the status of the company's nonvested restricted stock and changes |  |  |
|  | December 31, |
|  | 2023 |  |  | 2022 |  |  | 2021 |
|  | Restricted Shares |  |  | Weighted Average Grant-Date Fair Value |  |  | Restricted Shares |  |  | Weighted Average Grant-Date Fair Value |  |  | Restricted Shares |  |  | Weighted Average Grant-Date Fair Value |
Nonvested at beginning of year |  |  | 80,337 |  |  | $ | 52.53 |  |  |  | 41,699 |  |  | $ | 44.71 |  |  |  | 26,099 |  |  | $ | 38.05 |
Granted |  |  | 69,880 |  |  |  | 37.12 |  |  |  | 53,376 |  |  |  | 56.25 |  |  |  | 26,450 |  |  |  | 48.56 |
Vested |  |  | (21,695 | ) |  |  | 48.95 |  |  |  | (14,213 | ) |  |  | 43.26 |  |  |  | (9,600 | ) |  |  | 38.03 |
Forfeited |  |  | (18,989 | ) |  |  | 46.83 |  |  |  | (525 | ) |  |  | 61.14 |  |  |  | (1,250 | ) |  |  | 38.56 |
Nonvested at end of year |  |  | 109,533 |  |  | $ | 44.40 |  |  |  | 80,337 |  |  | $ | 52.53 |  |  |  | 41,699 |  |  | $ | 44.71 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (k) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1 + Details
Name: | us-gaap_ScheduleOfAssumptionsUsedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of employee stock purchase plan activity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration